Travere Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

Rhea-AI Summary

SAN DIEGO, Feb. 09, 2022 – Travere Therapeutics (NASDAQ: TVTX) announced that CEO Eric Dube will present at the virtual 11th Annual SVB Leerink Global Healthcare Conference on February 17, 2022, at 2:20 p.m. ET. A live webcast will be available on their investor relations website, and an archived replay will be accessible for 30 days. Travere Therapeutics is dedicated to supporting patients with rare diseases by developing life-changing therapies and collaborating with the rare disease community.

SAN DIEGO, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., chief executive officer, will present at the virtual 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 2:20 p.m. ET.

A live webcast will be available at https://ir.travere.com/events-presentations and an archived replay will be accessible for up to 30 days.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com

Contact:
Chris Cline, CFA
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879
IR@travere.com

FAQ

When will Eric Dube present at the SVB Leerink Global Healthcare Conference?

Eric Dube will present on February 17, 2022, at 2:20 p.m. ET.

How can I watch the SVB Leerink Global Healthcare Conference presentation?

You can watch the presentation live via a webcast on Travere Therapeutics' investor relations website.

What is the focus of Travere Therapeutics?

Travere Therapeutics focuses on developing therapies for patients with rare diseases.

How long will the conference presentation be available for replay?

The archived replay of the presentation will be available for 30 days.

What is the stock symbol for Travere Therapeutics?

The stock symbol for Travere Therapeutics is TVTX.